OCCIDENT
OCCIDENT is an international venture capital investor with offices in Munich and Zug, is owner-managed and invests own wealth. Its aim is to make a positive contribution to society through sustainable and meaningful investments. OCCIDENT invests in innovative deep tech start-ups with excellent technologies in the fields of life sciences, digital and high-tech with broad application possibilities and the potential for further value-generating developments. The geographic focus is Germany and Switzerland. The preferred stage for initial financing is from seed rounds or later and from 0.5 million euros. OCCIDENT distinguishes itself in particular by its in-depth knowledge of the technology and the versatile support offered to its portfolio companies by its competent team of experts.
OCCIDENT
Social Links:
Founded:
2014-01-01
Status:
Active
Contact:
+49 89 21539980
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Apple Mobile Web Clips Icon WordPress Wordpress Plugins Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Engal
Business Angel, Ventur Capital, Investor
FIDIASZ
FIDIASZ Enterpreneurial Venture Capital
Flucas Ventures
Flucas Ventures is an active venture capital investor.
International Incubator Hagenberg
Location, Venture Capital, Mentoring
J-Ventures
LP Driven Venture Capital Fund
NP Capital
International Venture Vapital Firm
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-07 | Invasight | OCCIDENT investment in Seed Round - Invasight | 4.5 M CHF |
| 2022-06-01 | Code Intelligence | OCCIDENT investment in Series A - Code Intelligence | 11 M EUR |
| 2022-05-03 | Tubulis | OCCIDENT investment in Series B - Tubulis | 60 M EUR |
| 2022-04-26 | Hemotune | OCCIDENT investment in Series B - Hemotune | 7.25 M CHF |
| 2020-08-14 | Hemotune | OCCIDENT investment in Series A - Hemotune | 5.1 M CHF |
| 2020-07-21 | Tubulis | OCCIDENT investment in Series A - Tubulis | 10.7 M EUR |
| 2020-06-24 | Code Intelligence | OCCIDENT investment in Series A - Code Intelligence | 2 M EUR |
| 2020-02-06 | Lunaphore | OCCIDENT investment in Series C - Lunaphore | 23.6 M USD |
| 2019-12-17 | Resistell AG | OCCIDENT investment in Series A - Resistell AG | 3.5 M CHF |
| 2019-08-06 | GNA Biosolutions | OCCIDENT investment in Series C - GNA Biosolutions | 13.5 M USD |